System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Systematic Review Epublish

PubMed: 39995679 DOI: 10.3389/fimmu.2025.1533651

Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues.

Front Immunol 16:1533651

Authors: Pengliang Xu, Huanming Yu, Hupo Bian, Dan Jia, Wenhui Li, Hongfeng Dong, Xiuhua Peng

Affiliations

  • Department of Thoracic Surgery, The First People's Hospital of Huzhou, Huzhou, China.
  • Department of Radiology, The First People's Hospital of Huzhou, Huzhou, China.
  • Department of Respiratory Medicine, The First People's Hospital of Huzhou, Huzhou, China.

Abstract

Background

Neoadjuvant immunotherapy (NIT) is a rapidly emerging paradigm for advanced resectable non-small cell lung cancer (NSCLC). However, there is no bibliometric analysis in this research field.

Objective

To analyze the hotspots and trends in the research of NIT for NSCLC and provide a reference for the study of NIT for lung cancer in China.

Methods

Retrieve literature related to NIT for NSCLC from Web of Science, PubMed, and Scopus databases up to September 10, 2024. Use CiteSpace and VOSviewer software visualization software to analyze the keywords of country, author, institution, and literature.

Results

There were 1575 references, and the overall annual publication volume showed an upward trend; Forde and Patrick M have published the most articles in the literature. The research hotspots mainly focus on chemotherapy, NIT for NSCLC, immunotherapy, neoadjuvant chemotherapy, pathological reactions, etc.

Conclusions

This is the first bibliometric study comprehensively summarizing NIT's research trends and development in NSCLC. Our bibliometric assessment provides a panoramic view of the research milieu surrounding NIT for NSCLC, encapsulating the present state, evolving trends, and potential future directions, particularly emphasizing the promise of immunochemotherapy.

MeSH

Cells, Lung, Cooperative Behavior, Neoplasms, Carcinoma, Non-Small-Cell Lung, Drug Therapy, Immunotherapy, Lung Neoplasms, Immune System Diseases, Small Cell Lung Carcinoma, Research, Software, Chemotherapy